PL1658039T3 - Zastosowanie biotyny lub pochodnej biotyny do rozjaśniania skóry i zwalczania plam starczych - Google Patents

Zastosowanie biotyny lub pochodnej biotyny do rozjaśniania skóry i zwalczania plam starczych

Info

Publication number: PL1658039T3
Authority: PL; Poland
Prior art keywords: biotin; skin; vitamin; derivative; age spots
Prior art date: 2003-08-26

Application number

PL04764050T

Other languages

English (en)

Inventor

Roland Jermann

Helmut Luther

Original Assignee

Dsm Ip Assets Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-26

Filing date

2004-08-12

Publication date

2008-10-31

2004-08-12 Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv

2008-10-31 Publication of PL1658039T3 publication Critical patent/PL1658039T3/pl

Links

YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title abstract 5
229960002685 biotin Drugs 0.000 title abstract 3
235000020958 biotin Nutrition 0.000 title abstract 3
239000011616 biotin Substances 0.000 title abstract 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 1
229960005070 ascorbic acid Drugs 0.000 title 1
150000001615 biotins Chemical class 0.000 title 1
230000000694 effects Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
206010040829 Skin discolouration Diseases 0.000 abstract 1
-1 biotin compound Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
206010024217 lentigo Diseases 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000001777 nootropic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicinal Preparation (AREA)

PL04764050T 2003-08-26 2004-08-12 Zastosowanie biotyny lub pochodnej biotyny do rozjaśniania skóry i zwalczania plam starczych PL1658039T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03018730		2003-08-26
EP04764050A EP1658039B1 (de)	2003-08-26	2004-08-12	Verwendung von biotin oder einem biotinderivat zusammen mit vitamin c zur aufhellung der haut und behandlung von altersflecken
PCT/EP2004/009048 WO2005020877A2 (de)	2003-08-26	2004-08-12	Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken

Publications (1)

Publication Number	Publication Date
PL1658039T3 true PL1658039T3 (pl)	2008-10-31

Family

ID=34203219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04764050T PL1658039T3 (pl)	2003-08-26	2004-08-12	Zastosowanie biotyny lub pochodnej biotyny do rozjaśniania skóry i zwalczania plam starczych

Country Status (12)

Country	Link
US (2)	US20050048012A1 (pl)
EP (2)	EP1872772B1 (pl)
JP (1)	JP4755985B2 (pl)
KR (1)	KR101088604B1 (pl)
CN (1)	CN1842318B (pl)
AT (1)	ATE396695T1 (pl)
BR (1)	BRPI0414010B1 (pl)
DE (1)	DE502004007294D1 (pl)
ES (2)	ES2547852T3 (pl)
MX (1)	MXPA06000464A (pl)
PL (1)	PL1658039T3 (pl)
WO (1)	WO2005020877A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007063223A (ja) *	2005-09-01	2007-03-15	Kobayashi Pharmaceut Co Ltd	しみ又はそばかす予防又は治療用経口組成物及び食品
JP2007063224A (ja) *	2005-09-01	2007-03-15	Kobayashi Pharmaceut Co Ltd	チロシナーゼ活性阻害剤
WO2007051596A1 (en) *	2005-11-03	2007-05-10	Dsm Ip Assets B.V.	Novel retinyl biotinates and use thereof
DE102006047156A1 (de) *	2006-09-29	2008-04-03	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
DE102006047157A1 (de) *	2006-09-29	2008-04-03	Beiersdorf Ag	Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
FR2913198B1 (fr) *	2007-03-01	2009-06-05	Oreal	Utilisation cosmetique d'une association de biotine et de vitamine cg.
ES2439582T3 (es) *	2007-03-12	2014-01-23	Dsm Ip Assets B.V.	Composiciones cosméticas
KR20100016303A (ko) *	2007-05-10	2010-02-12	디에스엠 아이피 어셋츠 비.브이.	광노화를 방지하기 위한 바이오틴의 용도
DE102008008554A1 (de) *	2008-02-12	2009-08-13	Sebapharma Gmbh & Co.	Kosmetische oder medizinische Zubereitung enthaltend Biotin
JP2009256326A (ja) *	2008-03-21	2009-11-05	Kose Corp	美白剤、及び皮膚外用剤
WO2015195404A1 (en)	2014-06-20	2015-12-23	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en)	2015-06-15	2016-12-22	The United States Of America, As Represented By The Secretary Department Of Health And Human Services	Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
US20170135969A1 (en)	2015-11-12	2017-05-18	Jds Therapeutics, Llc	Topical arginine-silicate-inositol for wound healing
CN109890384A (zh)	2016-09-01	2019-06-14	Jds治疗有限公司	生物素镁组合物和使用方法
AU2017345814B2 (en)	2016-10-21	2022-07-28	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Molecular nanotags
US10878941B2 (en) *	2017-05-22	2020-12-29	Zeyix Llc	Perpetual bioinformatics and virtual colorimeter expert system
WO2019133727A1 (en)	2017-12-29	2019-07-04	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
GB201800909D0 (en) *	2018-01-19	2018-03-07	Biocel Ltd	Compositions and methods relating to amnion
US11701322B2 (en)	2018-03-23	2023-07-18	Mary Kay Inc.	Topical compositions and methods
US11246886B2 (en) *	2018-09-06	2022-02-15	Nutrition 21, Llc	Treatment of autism and autism spectrum disorders with biotin compositions
CA3165102A1 (en)	2019-12-16	2021-06-24	Nutrition 21, Llc	Methods of production of arginine-silicate complexes
WO2022056078A1 (en)	2020-09-11	2022-03-17	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Rnase h-assisted detection assay for rna (radar)
CN114504549B (zh) *	2022-02-24	2023-11-24	北京斯利安药业有限公司	生物素的水性凝胶剂及其制备方法和应用
WO2024191684A1 (en)	2023-03-10	2024-09-19	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH656067A5 (de) *	1981-12-10	1986-06-13	Richardson Vicks Inc	Kosmetisches haarpflege- oder hautpflegemittel.
JPS6442414A (en) *	1987-08-10	1989-02-14	Kanebo Ltd	Skin-beautifying cosmetic
JPH02215707A (ja) *	1989-02-15	1990-08-28	Chisso Corp	皮膚化粧料
GB9006785D0 (en) *	1990-03-27	1990-05-23	Leung Lit Hung	Composition and methods for treatment of acne vulgaris and retardation of ageing
IT1254045B (it) *	1991-12-31	1995-09-06	Lifegroup Spa	Derivati idrosolubili della biotina e relative composizioni terapeutiche
DE4242876C2 (de) *	1992-12-18	1997-11-27	Beiersdorf Ag	Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
JPH0797322A (ja) *	1993-09-29	1995-04-11	Shiseido Co Ltd	一重項酸素消去剤
JPH07233046A (ja) *	1993-12-28	1995-09-05	Kose Corp	外用剤
DE4444238A1 (de) *	1994-12-13	1996-06-20	Beiersdorf Ag	Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
WO1997025883A1 (de) *	1996-01-17	1997-07-24	Friedrich Kisters	Aminosäuren-präparat zur haarwuchsförderung
DE19701651A1 (de) *	1997-01-18	1998-07-23	Rovi Gmbh Handelsgesellschaft	Wäßrige Zusammensetzung mit biotinhaltigen Liposomen
IN2000KO00299A (pl) *	1999-05-28	2005-11-18	Johnson & Johnson Consumer
US6551604B1 (en) *	1999-06-28	2003-04-22	The Procter & Gamble Company	Skin care compositions
DE19941769A1 (de) *	1999-09-02	2001-03-08	Beiersdorf Ag	Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
JP4786127B2 (ja) *	2002-07-12	2011-10-05	任康高田	色素沈着改善治療薬
EP1587377A2 (en) *	2003-01-31	2005-10-26	The Procter & Gamble Company	Means for improving the appearance of mammalian keratinous tissue
EP1449514A1 (de) *	2003-02-13	2004-08-25	Beiersdorf AG	Hautpflegeprodukte mit Retinoiden, Ubichinonen sowie Biotin oder Carnitin

2004
- 2004-04-28 US US10/833,983 patent/US20050048012A1/en not_active Abandoned
- 2004-08-12 WO PCT/EP2004/009048 patent/WO2005020877A2/de active IP Right Grant
- 2004-08-12 US US10/569,784 patent/US20070020206A1/en not_active Abandoned
- 2004-08-12 BR BRPI0414010-9A patent/BRPI0414010B1/pt active IP Right Grant
- 2004-08-12 MX MXPA06000464A patent/MXPA06000464A/es unknown
- 2004-08-12 JP JP2006524277A patent/JP4755985B2/ja not_active Expired - Lifetime
- 2004-08-12 EP EP07016471.0A patent/EP1872772B1/de not_active Expired - Lifetime
- 2004-08-12 ES ES07016471.0T patent/ES2547852T3/es not_active Expired - Lifetime
- 2004-08-12 KR KR1020067003887A patent/KR101088604B1/ko not_active Expired - Lifetime
- 2004-08-12 AT AT04764050T patent/ATE396695T1/de not_active IP Right Cessation
- 2004-08-12 DE DE502004007294T patent/DE502004007294D1/de not_active Expired - Lifetime
- 2004-08-12 CN CN200480024360XA patent/CN1842318B/zh not_active Expired - Lifetime
- 2004-08-12 PL PL04764050T patent/PL1658039T3/pl unknown
- 2004-08-12 EP EP04764050A patent/EP1658039B1/de not_active Expired - Lifetime
- 2004-08-12 ES ES04764050T patent/ES2304161T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE502004007294D1 (de)	2008-07-10
JP2007503407A (ja)	2007-02-22
JP4755985B2 (ja)	2011-08-24
MXPA06000464A (es)	2006-04-11
BRPI0414010B1 (pt)	2021-03-16
EP1658039B1 (de)	2008-05-28
KR101088604B1 (ko)	2011-11-30
CN1842318A (zh)	2006-10-04
KR20060069472A (ko)	2006-06-21
CN1842318B (zh)	2011-04-13
ES2547852T3 (es)	2015-10-09
EP1872772A1 (de)	2008-01-02
ATE396695T1 (de)	2008-06-15
ES2304161T3 (es)	2008-09-16
US20070020206A1 (en)	2007-01-25
WO2005020877A2 (de)	2005-03-10
EP1872772B1 (de)	2015-08-05
EP1658039A2 (de)	2006-05-24
BRPI0414010A (pt)	2006-10-24
WO2005020877A3 (de)	2005-07-14
US20050048012A1 (en)	2005-03-03

Publication	Publication Date	Title
PL1658039T3 (pl)	2008-10-31	Zastosowanie biotyny lub pochodnej biotyny do rozjaśniania skóry i zwalczania plam starczych
MXPA05008216A (es)	2005-10-05	Medios para mejorar la apariencia del tejido queratinoso mamifero.
WO1996019099A3 (fr)	1997-04-10	Utilisation de la vitamine c ou de ses derives ou analogues pour stimuler la synthese de l'elastine cutanee
AU4114296A (en)	1996-06-26	Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
ATE497766T1 (de)	2011-02-15	Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
AU4775099A (en)	2000-01-10	Trichological lotion for topical use
WO2004000227A3 (en)	2004-04-08	Use of thio-oxindole derivatives in treatment of skin disorders
WO2004032873A3 (en)	2004-07-29	Therapeutic combination of carnitine and antioxidant polyphenols
MXPA03010429A (es)	2004-03-09	Producto topico con indicador visual.
MXPA03005510A (es)	2004-04-20	Composiciones y metodos para tratar hiperpigmentacion.
CA2571796A1 (en)	2006-01-19	Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
SI1638582T1 (sl)	2009-10-31	Uporaba hialuronske kisline za pripravo sestav za zdravljenje ponavljajoäśih se aft v ustni votlini
WO2003090688A3 (en)	2007-11-15	Enhancement of human epidermal melanogenesis
DE10292279D2 (de)	2004-05-06	Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
WO2000016734A3 (en)	2000-08-24	Hair treatment composition
EP0755685A4 (en)	2000-05-03	PHARMACEUTICAL COMPOSITION FOR TREATING LATE DYSKINESIA
ATE303145T1 (de)	2005-09-15	Arzneimittel enthaltend einen effektor des glutathionmetabolismus (ambroxol) zusammen mit alpha-liponsäure im rahmen der behandlung des diabetes mellitus
DE602004000690D1 (de)	2006-05-24	Hautkosmetische Zubereitungen zur Depigmentierung und deren Verwendung
TW200616666A (en)	2006-06-01	Skin-lightening preparation for external use and method of skin lightening
US20100124561A1 (en)	2010-05-20	Anti-Aging Product
Piraccini et al.	2024	Treatment of Nail Fragility in Males and Females
AU2002331892A1 (en)	2004-01-06	Topical pharmaceutical composition to treat hyperpigmentation of the skin
BRPI0510903A (pt)	2008-01-08	composição cosmética de spray, composição cosmética de spray desodorante, produto e método de tratamento cosmético
HK1089361A1 (en)	2006-12-01	Topical administration of vasoactive vitamin b3 compounds for promoting sleep
HK1119088A1 (en)	2009-02-27	Use of l-2-thiohistidine or one of its derivatives as a depigmenting agent in cosmetics l-2-